Harrison Silva

550 total citations
7 papers, 122 citations indexed

About

Harrison Silva is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Harrison Silva has authored 7 papers receiving a total of 122 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Harrison Silva's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (4 papers) and Virus-based gene therapy research (2 papers). Harrison Silva is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (4 papers) and Virus-based gene therapy research (2 papers). Harrison Silva collaborates with scholars based in United States. Harrison Silva's co-authors include Marcela V. Maus, Amanda A. Bouffard, Stefanie R. Bailey, Michael C. Kann, Rebecca C. Larson, Marc Wehrli, Mark B. Leick, Korneel Grauwet, Bryan D. Choi and Max Jan and has published in prestigious journals such as Blood, Cancer Cell and Cancer Research.

In The Last Decade

Harrison Silva

7 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harrison Silva United States 4 102 47 34 33 30 7 122
Xinyi Teng China 5 125 1.2× 63 1.3× 42 1.2× 52 1.6× 28 0.9× 10 171
Janaki Manoja Vinnakota Germany 5 74 0.7× 34 0.7× 19 0.6× 44 1.3× 30 1.0× 9 113
Alexis Cuffel France 6 105 1.0× 60 1.3× 34 1.0× 45 1.4× 20 0.7× 7 140
Kristen Spitler United States 5 168 1.6× 61 1.3× 61 1.8× 48 1.5× 48 1.6× 10 182
Radhika Thokala United States 5 129 1.3× 49 1.0× 48 1.4× 65 2.0× 51 1.7× 7 163
Austin K. Rennels United States 4 156 1.5× 55 1.2× 35 1.0× 80 2.4× 57 1.9× 4 191
Diana Bouhassira United States 4 84 0.8× 30 0.6× 24 0.7× 30 0.9× 28 0.9× 7 125
Meghan Menges United States 8 89 0.9× 25 0.5× 21 0.6× 50 1.5× 27 0.9× 16 106
Jinlong Xu China 6 139 1.4× 42 0.9× 41 1.2× 37 1.1× 51 1.7× 16 177
Leili Moezzi Australia 3 132 1.3× 42 0.9× 31 0.9× 81 2.5× 69 2.3× 5 171

Countries citing papers authored by Harrison Silva

Since Specialization
Citations

This map shows the geographic impact of Harrison Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harrison Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harrison Silva more than expected).

Fields of papers citing papers by Harrison Silva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harrison Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harrison Silva. The network helps show where Harrison Silva may publish in the future.

Co-authorship network of co-authors of Harrison Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Harrison Silva. A scholar is included among the top collaborators of Harrison Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harrison Silva. Harrison Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Korell, Felix, Irene Scarfò, Harrison Silva, et al.. (2025). Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma. Leukemia. 39(10). 2452–2464. 1 indexed citations
2.
Korell, Felix, Michael Olson, Diego Salas‐Benito, et al.. (2024). Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics. Science Translational Medicine. 16(750). eadk7640–eadk7640. 14 indexed citations
3.
Silva, Harrison, Marc Wehrli, Michael C. Kann, et al.. (2024). CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML. Blood. 145(7). 720–731. 11 indexed citations
4.
Korell, Felix, Michael Olson, Diego Salas‐Benito, et al.. (2023). Abstract 4098: Chimeric antigen receptor (CAR) T cells overexpressing Bcl-xL increase proliferation and antitumor activity alone and in combination with BH3 mimetics. Cancer Research. 83(7_Supplement). 4098–4098. 3 indexed citations
5.
Leick, Mark B., Harrison Silva, Irene Scarfò, et al.. (2022). Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia. Cancer Cell. 40(5). 494–508.e5. 88 indexed citations
6.
Korell, Felix, et al.. (2022). Combinatorial Effects of BH3 Mimetics and CAR T Cells Targeting T-Cell Lymphomas. Blood. 140(Supplement 1). 499–500. 1 indexed citations
7.
Leick, Mark B., Harrison Silva, Irene Scarfò, et al.. (2021). Rational Chemical and Genetic Modifications Enhance Avidity and Function of CD70-Directed CAR-T-Cells for Myeloid Leukemia. Blood. 138(Supplement 1). 405–405. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026